Big-name sponsors are yanking their support from New York’s 2017 Puerto Rican Day Parade after organizers decided to honor a man labeled by U.S. officials as a terrorist.
Coca-Cola (CCE), AT&T (T, Tech30), JetBlue (JBLU), Univision (UVN), The Daily News, the New York Yankees and Goya Foods are among the companies that have decided not to sponsor the event, which is scheduled to take place on June 11. It’s expected to attract more than one million people.
The 2017 parade is set to honor Oscar L贸pez Rivera — a man who was involved with FALN, a Puerto Rican nationalist group that was linked to terrorist attacks in several US cities in the 1970s. Bombings that are believed to have been carried out by the group killed five people and injured dozens more.
Puerto Rico has been a US territory since 1898, and various separatist movements have cropped up ever since. Today, Puerto Rico is in the throes of an economic crisis that has spurred many to flee the island for the US mainland. Some blame Puerto Rico’s current troubles, at least in part, on the US government.
dow jones stock: California Resources Corporation(CRC)
- [By Andrew Efimoff]
WTI crude oil plunged 3.11 percent on Friday to $48.99 a barrel. Below are the biggest energy losers for the day:
California Resources Corporation (NYSE: CRC): -19.22% Dynamic Materials (NASDAQ: BOOM): -12.39% Clayton Williams Energy (NYSE: CWEI): -11.45% Dynergy (NYSE: DYN): -11.91% EP Energy Corporation (NYSE: EPE): -11.20% Mexco Energy (NYSE: MXC) -10.90% Whiting Petroleum (NYSE: WLL) -10.79% Southwestern Energy Company (NYSE: SWN) -10.79% SM Energy Company (NYSE: SM) -10.38% Real Goods Solar (NASDAQ: RGSE) -10.34%
Posted-In: Commodities After-Hours Center Markets Movers
- [By Matthew DiLallo]
That sell-off in the oil market weighed on financially challenged oil stocks, which will struggle if crude continues dropping. Among the biggest losers were Abraxas Petroleum (NASDAQ:AXAS), Whiting Petroleum (NYSE:WLL), Denbury Resources (NYSE:DNR), California Resources (NYSE:CRC), and Cobalt International Energy (NYSE:CIE).
dow jones stock: Bellerophon Therapeutics, Inc.(BLPH)
- [By Alex McGuire]
Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…
Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%
The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.
dow jones stock: Pacific Mercantile Bancorp(PMBC)
- [By Lisa Levin]
Shares of Pacific Mercantile Bancorp (NASDAQ: PMBC) were down 24 percent to $5.78. Pacific Mercantile Bancorp reported a Q3 loss of $30.5 million on revenue of $10.2 million for its third quarter.
dow jones stock: SemiLEDS Corporation(LEDS)
- [By Lisa Levin]
SemiLEDs Corporation (NASDAQ: LEDS) was down, falling around 17 percent to $6.75 following Q2 earnings report. SemiLEDS reported a Q3 loss of $1.06 per share on revenue of $2.4 million.
- [By Monica Gerson]
SemiLEDs Corporation (NASDAQ: LEDS) is estimated to post its quarterly earnings.
Staffing 360 Solutions Inc (NASDAQ: STAF) is expected to post a quarterly loss at $0.28 per share.
dow jones stock: STARWOOD PROPERTY TRUST, INC.(STWD)
- [By WWW.MONEYSHOW.COM]
Starwood Property Trust (STWD) is a finance REIT, which means it makes or owns real estate mortgages rather than owning commercial property. The bulk of Starwood Property’s business is to make and hold commercial property mortgages.
dow jones stock: Evoke Pharma, Inc.(EVOK)
- [By Cameron Saucier]
Evoke (Nasdaq: EVOK) is a pharmaceutical company that develops drug candidates intended to treat gastrointestinal diseases. EVOK rose 73% last month after it announced positive guidance from the FDA for Gimoti, a patented nasal delivery drug that is intended to treat gastroparesis in adult women. The positive results were from a second pre-NDA (New Drug Application) meeting Evoke had with the FDA. EVOK is currently trading at $2.67 per share and is down 9.83% as of Jan. 9 YOY.